Predictions
Valneva SE
Start price
Target price
Perf. (%)
€8.01
05.09.22
05.09.22
-
05.10.26
05.10.26
-57.57%
11.03.24
11.03.24
Probably not worthwhile Investment
MorphoSys AG
Start price
Target price
Perf. (%)
€16.57
05.09.22
05.09.22
-
05.10.26
05.10.26
293.97%
11.03.24
11.03.24
Probably not worthwhile Investment
Porsche Automobil Holding SE
Start price
Target price
Perf. (%)
€69.70
05.09.22
05.09.22
€59.00
05.09.23
05.09.23
-24.68%
22.03.23
22.03.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
negative Cash Flow expected
Bad rating
Solaredge Technologies Inc
Start price
Target price
Perf. (%)
€266.35
05.09.22
05.09.22
€300.00
05.09.23
05.09.23
16.01%
17.09.22
17.09.22
High Investments for future growth
Leading role in innovation
Differentiated customer and product portfolio
Sustainability is very important
Rock Tech Lithium Inc.
Start price
Target price
Perf. (%)
€2.62
05.09.22
05.09.22
€4.00
05.09.23
05.09.23
-6.88%
17.09.22
17.09.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Immobiliere Frey
Start price
Target price
Perf. (%)
€33.60
05.09.22
05.09.22
€15.00
05.09.23
05.09.23
2.38%
17.09.22
17.09.22
Could be worthwhile Investment >10% per year
Blue Apron Holdings Inc.
Start price
Target price
Perf. (%)
€67.61
05.09.22
05.09.22
€336.00
05.09.23
05.09.23
-3.83%
19.09.22
19.09.22
Could be very worthwhile Investment >20% year
Novacyt S.A.
Start price
Target price
Perf. (%)
€1.06
05.09.22
05.09.22
-
05.09.23
05.09.23
-46.97%
24.04.23
24.04.23
Probably not worthwhile Investment
China SXT Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.19
05.09.22
05.09.22
-
05.09.23
05.09.23
-90.57%
06.09.23
06.09.23
Revenue growth >5% per year expected
Probably not worthwhile Investment
Storytel Ab
Start price
Target price
Perf. (%)
€3.98
05.09.22
05.09.22
-
05.09.23
05.09.23
18.75%
10.11.22
10.11.22
Revenue growth >5% per year expected
Probably not worthwhile Investment
ShiftPixy Inc.
Start price
Target price
Perf. (%)
€13.48
05.09.22
05.09.22
-
05.09.23
05.09.23
113.53%
09.09.22
09.09.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Allakos Inc
Start price
Target price
Perf. (%)
€4.72
04.09.22
04.09.22
-
04.09.23
04.09.23
-13.68%
02.04.23
02.04.23
Risky Investment
Rubius Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.14
04.09.22
04.09.22
-
04.09.23
04.09.23
-92.50%
05.09.23
05.09.23
Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.12
04.09.22
04.09.22
-
04.09.23
04.09.23
-11.64%
15.10.22
15.10.22
Could be worthwhile Investment >10% per year
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€2.63
04.09.22
04.09.22
-
04.09.23
04.09.23
-6.99%
18.09.22
18.09.22
Could be worthwhile Investment >10% per year
Stellantis N.V.
Start price
Target price
Perf. (%)
€13.18
04.09.22
04.09.22
-
04.09.23
04.09.23
7.04%
10.11.22
10.11.22
Could be worthwhile Investment >10% per year
Farfetch Ltd
Start price
Target price
Perf. (%)
€9.52
04.09.22
04.09.22
€5.00
04.09.23
04.09.23
10.78%
17.09.22
17.09.22
Revenue decline/stagnation expected
Very low/no dividend yield expected
very negative Cash Flow expected
High risks in the balance sheet
First Hydrogen Corp.
Start price
Target price
Perf. (%)
€3.82
04.09.22
04.09.22
€1.00
04.09.23
04.09.23
-7.33%
17.09.22
17.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
overvalued
Allakos Inc
Start price
Target price
Perf. (%)
€4.72
04.09.22
04.09.22
€12.00
04.09.23
04.09.23
-2.53%
17.09.22
17.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Atlanticus Holdings Corp
Start price
Target price
Perf. (%)
€28.60
04.09.22
04.09.22
€11.00
04.09.23
04.09.23
-
17.09.22
17.09.22
Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Mastercard Inc. A
Start price
Target price
Perf. (%)
€327.80
04.09.22
04.09.22
€350.00
04.09.23
04.09.23
4.06%
01.12.22
01.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Future proof or reliable business model
Mastercard Inc.
Start price
Target price
Perf. (%)
€16.20
04.09.22
04.09.22
€18.00
04.09.23
04.09.23
4.32%
25.01.23
25.01.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group